Category Archives: Patently BIOtech

BIO Commends Senate Judiciary Committee Passage of Patent Reform Act of 2011

BIO Commends Senate Judiciary Committee Passage of Patent Reform Act of 2011 Bipartisan, consensus-oriented approach will strengthen nation’s patent system   Washington, D.C. (February 3, 2011) – Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement on the passage today of The Patent Reform Act of 2011 (S. 23) by the Senate Judiciary Committee: “BIO commends the Senate Judiciary Committee for passing The Patent Reform Act of 2011.  We appreciate the Read More >

Patently BIOtech  |  1 Comment  |  Email This Post
Tags: , , , , ,

Patent backlog hinders nation’s job creation

Article from the Milwaukee Journal Sentinel with interesting numbers.  Highlights: -Many of the missing jobs – hundres of thousands or possibly millions – are buried under the backlog of 1.2 million unprocessed patent applicatoins that have accumulated over the past 10 years at the U.S. Patent and Trademark Office. -A single U.S. patent can create three to ten jobs.  -Nothaft estimates more than 2 million new jobs are buried in the backlog -”Innovation is our Read More >

Patently BIOtech  |  1 Comment  |  Email This Post
Tags: , , , , , , , , ,

President Obama’s Plan to Win the Future by Catalyzing Invention, Innovation, and Economic Growth through Patent Reform

The White House Office of Public Engagement released the patent factsheet, “President Obama’s Plan to Win the Future by Catalyzing Invention, Innovation and Economic Growth through Patent Reform,” the night of Obama’s Jan. 25, 2011, State of the Union address.  Here are some highlights. “ Improve the Operations of the Patent and Trademark Office (PTO): The President’s budget enables the PTO to address a backlog of over 700,000 patent applications.  Promote U.S. Cooperation with International Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , ,

BIO’s Intellectual Property Counsels’ Committee Spring Conference and Meeting: Seattle

Over the past eight years, BIO’s semiannual IP Counsels Committee Conference has become a popular and growing event among our members’ IP and legal professionals. Our upcoming 2011 Spring IPCC Conference in Seattle, WA on April 13-15 will be an excellent opportunity for IP professionals to hear, listen, and learn about current and projected topics related to biotechnology IP. We invite you to join us in an informal, fun and informative setting to meet fellow in-house Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , ,

Brazilian Attorney General of the Union restricts ANVISA’s role in pharmaceutical patent review

We are receiving reports from Brazil that the Brazilian Attorney General of the Union (AGU) has adopted a position restricting the role of the National Agency for Sanitary Surveillance (ANVISA) in the patenting process for pharmaceutical products and processes.  Due to a lack of clarity in the Industrial Property Law, ANVISA has used its prior consent role to reject patent applications on the basis of novelty and inventiveness which is officially the role of the Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , ,